<DOC>
	<DOCNO>NCT00702143</DOCNO>
	<brief_summary>Evaluate 18F-AV-45 positron emission tomography ( PET ) image distinguish healthy control subject , subject Alzheimer 's disease ( AD ) Mild cognitive impairment ( MCI ) .</brief_summary>
	<brief_title>A Phase II Trial 18F-AV-45 Positron Emission Tomography ( PET ) Imaging Healthy Volunteers , Patients With Mild Cognitive Impairment ( MCI ) Patients With Alzheimer 's Disease ( AD )</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Mild Cognitive Impairment</mesh_term>
	<criteria>Inclusion Criteria AD : Male female &gt; =50 year age Meet National Institute Neurological Communicative Diseases Stroke/Alzheimer 's Disease Related Disorders Association ( NINCDS ) criteria probable AD MMSE score 1024 Inclusion Criteria MCI : Male female &gt; =50 year age Have Clinical Dementia Rating ( CDR ) 0.5 MMSE &gt; 24 Normal subject : Male female &gt; =50 year age MMSE &gt; =29 Normal psychometric test battery screen Provide inform consent Have history current diagnosis neurologic disease Have currently diagnosis neurodegenerative disease Have participate experimental therapy target amyloid plaque</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
</DOC>